Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Hamad Ibrahim Al-Ashqar"'
Autor:
Hamad Ibrahim Al-Ashqar, Mohammed Al-Quaiz, Saleim Towfeig Dahab, Musthafa Chalikandy Peedikayil
Publikováno v:
Annals of Saudi Medicine, Vol 33, Iss 2, Pp 119-123 (2013)
BACKGROUND AND OBJECTIVES: Entecavir is a nucleoside analog used in the treatment of chronic hepatitis B. The efficacy of ETV has not been studied in the Saudi population. The objective of the study was to find undetectable HBV DNA after 48 weeks com
Externí odkaz:
https://doaj.org/article/e2e5db61a6824e2890e28a23d931079f
Autor:
Ibrahim Al Traif, Mohammed A. Al Balwi, Ibrahim Abdulkarim, Fayaz A. Handoo, Hamdan Saleh Alqhamdi, Melfi Alotaibi, Abdulrahman Aljumah, Hamad Ibrahim Al Ashqar, Khalid Bzeizi, Mohammed Al Quaiz, Abduljaleel Alalwan, Waleed Al Hamoudi, Khalid Alswat, Faisal Sanai, Ayman Abdo
Publikováno v:
Annals of Saudi Medicine, Vol 33, Iss 1, Pp 10-12 (2013)
BACKGROUND AND OBJECTIVES: Hepatitis C virus (HCV) genotype (G) knowledge is essential for determining type, duration and rate of response to antiviral therapy, possible route of HCV transmission, and future vaccine development. Our aim was to study
Externí odkaz:
https://doaj.org/article/b2a7425cb056435b835c385355365e9d
Autor:
Mohammed Alquaiz, Saleim Towfeig Dahab, Musthafa Chalikandy Peedikayil, Hamad Ibrahim Al-Ashqar
Publikováno v:
Annals of Saudi Medicine, Vol 33, Iss 2, Pp 119-123 (2013)
BACKGROUND AND OBJECTIVES: Entecavir is a nucleoside analog used in the treatment of chronic hepatitis B. The efficacy of ETV has not been studied in the Saudi population. The objective of the study was to find undetectable HBV DNA after 48 weeks com
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::05e107ceba0c331dea4020b8b2fe4e6b
https://www.annsaudimed.net/doi/full/10.5144/0256-4947.2013.119
https://www.annsaudimed.net/doi/full/10.5144/0256-4947.2013.119